Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Germany Government comments on Industrial Hemp Liberalisation bill ...
  • Belgium List of notified herbal products for smoking is updated ...
  • France Medical cannabis experiment likely to be delayed after government shakeup ...
  • United Kingdom FSA suggests acceptable THC content in CBD novel foods ...
  • Spain Survey shows daily cannabis use is down while occasional use is up ...
  • South Africa Cannabis trade legislation could be on the table in Parliament early next year ...
  • United States DEA hearings begin on proposal to reschedule cannabis ...
  • Switzerland Basel extends cannabis pilot project and includes new products ...
  • Czech Republic Decree simplifying medical cannabis prescription process proposed ...
  • Brazil Anvisa puts review of medical cannabis regulation on agenda ...
  • Denmark Trial scheme to prescribe medical cannabis made permanent ...
  • Europe ECR proposes including cannabis in EU goal to be tobacco-free by 2040 ...
View all
News analysis

Avazo has its collar felt by the FDA/FTC over ‘unsubstantiated COVID-19 claims’

Written by || 14th December 2020 || News analysis | Companies | Health and science | US federal regulation | GeographiesNorth America United States

Another company has been warned by the US Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) to stop claiming CBD can cure or mitigate the symptoms of COVID-19
Read full article

Download the full news analysis

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber

Login

Keep me logged in


Freddie Dawson

Senior news editor
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the CannIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.